Necessary for IL-12-Mediated Regression of the The CXC Chemokines IP-10 and Mig Are

The role of the non-ELR-containing CXC chemokines IP-10 and Mig in antitumor activity induced by systemic treatment with IL-12 was examined in mice bearing the murine renal adenocarcinoma RENCA. IL-12 treatment produces a potent antitumor effect that is associated with tumor infiltration by CD8 1 T lymphocytes. The regression of tumor is associated with the elevated expression of the IFN- g -inducible chemokines IP-10 and Mig within the tumor tissue. IP-10 and Mig have been shown to function as chemoattractants for activated T lymphocytes. In animals treated with rabbit polyclonal Abs specific for IP-10 and for Mig, the IL-12-induced regression of RENCA tumors was partially abrogated. This effect was associated with a dramatic inhibition of T cell infiltration. Thus, it appears that IL-12-dependent, T cell-mediated antitumor activity requires the intermediate expression of IP-10 and Mig to recruit antitumor effector T cells to the tumor site. The Journal of Immunology, 1998, 161: 927–932. shown agarose-formaldehyde gel, and blotted by capillary transfer onto nylon membranes. The blots prehybridized 6 to 18 h at 42°C in 50% formamide, 1% SDS, 5 3 SSC, 1 3 Denhardt’s solution (0.02% Ficoll, 0.02% BSA, and 0.02% polyvinylpyr-rolidine), 0.25 mg/ml denatured salmon sperm DNA, and 50 mM sodium phosphate buffer, pH 6.5. Hybridization was conducted at 42°C for 12 to 18 h with 10 7 cpm of denatured probe. The filters were washed twice for 15 min each time at 55°C in 0.1% SDS-0.5 3 SSC. The blots were then exposed using XAR-5 x-ray film (Eastman Kodak, Rochester, NY) with DuPont (Wilmington, DE) Cronex Lightening Plus intensifying screens at 2 70°C. Expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used as an internal control and was applied in all experiments.Semiquantitative RT-PCR analysis of perforin mRNA was conducted as reported previously (6, 25, 32). One microgram of total RNA was amplified using an oligo(dT) antisense primer and AMV reverse transcriptase at 42°C for 1 h. The RT reaction products were used undiluted or at a 1/10 dilution for PCR amplification using 20 mM sense and antisense primers (see be- low) and Taq polymerase. PCR reactions were conducted in a Perkin-Elmer/Cetus DNA Thermal Cycler for 15 cycles (denaturation, 1 min, 94°C; annealing, 1 min, 60°C; amplification, 2 min, 72°C). The primer sequences used were as follows: perforin antisense primer, GGTGGAGT GGAGGTTTTTGTACC; and perforin sense primer, CAGAATGCAAG CAGAAGCACAAG (perforin product size, 486 bp). These primers were chosen from separate exons to ensure

[1]  P. Leonard,et al.  Interleukin-12 , 2012, BioDrugs.

[2]  P. Wen,et al.  Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors , 1995, Cancer Immunology, Immunotherapy.

[3]  C. Bucana,et al.  Expression of theJE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells , 1994, Cancer Immunology, Immunotherapy.

[4]  J. Farber Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.

[5]  J. Teruya-Feldstein,et al.  Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo. , 1997, Blood.

[6]  L. Koniaris,et al.  Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Burdach,et al.  Combined chemokine and cytokine gene transfer enhances antitumor immunity , 1996, Nature Medicine.

[8]  R. Whyte,et al.  Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases , 1996, The Journal of experimental medicine.

[9]  Simon A. Jones,et al.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.

[10]  D. Goeddel,et al.  RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. , 1996, Human gene therapy.

[11]  A. Angiolillo,et al.  Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. , 1996, Blood.

[12]  J. Finke,et al.  Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. , 1996, Journal of immunology.

[13]  J. Wigginton,et al.  Antitumor activity of interleukin 12 in preclinical models , 1996, Cancer Chemotherapy and Pharmacology.

[14]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[15]  L. Koniaris,et al.  Human Mig chemokine: biochemical and functional characterization , 1995, The Journal of experimental medicine.

[16]  P. Leder,et al.  Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Bar‐eli,et al.  Suppression of tumor growth and metastasis of murine renal adenocarcinoma by syngeneic fibroblasts genetically engineered to secrete the JE/MCP-1 cytokine. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[18]  D. Taub,et al.  Human Interferon-inducible Protein 10 Is a Potent Inhibitor of Angiogenesis in Vivo , 1995 .

[19]  P. Leder,et al.  The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation , 1995, The Journal of experimental medicine.

[20]  Hendrzak Ja,et al.  Interleukin-12. Biologic activity, therapeutic utility, and role in disease. , 1995 .

[21]  R. Strieter,et al.  Role of C‐X‐C chemokines as regulators of angiogenesis in lung cancer , 1995, Journal of leukocyte biology.

[22]  B. Sykes,et al.  Structure‐activity relationships of chemokines , 1995, Journal of leukocyte biology.

[23]  R. D'Amato,et al.  Inhibition of angiogenesis in vivo by interleukin 12. , 1995, Journal of the National Cancer Institute.

[24]  J. Orange,et al.  Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids , 1995, The Journal of experimental medicine.

[25]  L. Luistro,et al.  Role of Interferon‐γ in Mediating the Antitumor Efficacy of Interleukin‐12 , 1995 .

[26]  M. Baggiolini,et al.  Interleukin-8 and the chemokine family. , 1995, International journal of immunopharmacology.

[27]  L. Luistro,et al.  Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12. , 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[28]  G. Trinchieri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[29]  J. Tschopp,et al.  A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Dorf,et al.  Inhibition of in vivo tumor growth by the beta chemokine, TCA3. , 1994, Journal of immunology.

[31]  G. Trinchieri,et al.  The role of interleukin 12 in the immune response, disease and therapy. , 1994, Immunology today.

[32]  G. Trinchieri,et al.  Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction , 1994, The Journal of experimental medicine.

[33]  R. Schreiber,et al.  Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. , 1994, Journal of immunology.

[34]  B. Dewald,et al.  Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. , 1994, The Journal of biological chemistry.

[35]  M. Gately,et al.  Antitumor activity of interleukin-12. , 1994, Clinical immunology and immunopathology.

[36]  J. Finke,et al.  Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2. , 1994, The American journal of pathology.

[37]  C. Bucana,et al.  Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. , 1994, Cancer immunology, immunotherapy : CII.

[38]  L. Luistro,et al.  Antitumor and antimetastatic activity of interleukin 12 against murine tumors , 1993, The Journal of experimental medicine.

[39]  A. Cesano,et al.  Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. , 1993, Journal of immunology.

[40]  L. Azzoni,et al.  Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. , 1993, Journal of immunology.

[41]  P. Leder,et al.  IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo , 1993, The Journal of experimental medicine.

[42]  G. Trinchieri,et al.  Interleukin-12 and its role in the generation of TH1 cells. , 1993, Immunology today.

[43]  D. Taub,et al.  Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells , 1993, The Journal of experimental medicine.

[44]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[45]  E. Klein,et al.  T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. , 1993, Cancer research.

[46]  E. Klein,et al.  Cancer immunotherapy: are the results discouraging? Can they be improved? , 1992, Advances in cancer research.

[47]  B. Rollins,et al.  Suppression of tumor formation in vivo by expression of the JE gene in malignant cells , 1991, Molecular and cellular biology.

[48]  E. Podack,et al.  A central role of perforin in cytolysis? , 1991, Annual review of immunology.

[49]  J. Farber A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Sayers,et al.  Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo. , 1990, Cancer research.

[51]  G. Trinchieri,et al.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.

[52]  Y. Ohmori,et al.  IFN-gamma and IFN-beta independently stimulate the expression of lipopolysaccharide-inducible genes in murine peritoneal macrophages. , 1989, Journal of immunology.

[53]  C. Tannenbaum,et al.  Characterization of lipopolysaccharide-induced macrophage gene expression. , 1988, Journal of immunology.

[54]  M. Brunda,et al.  The anti‐tumor effect of recombinant interferon alpha or gamma is influenced by tumor location , 1987, International journal of cancer.

[55]  S. Rosenberg,et al.  Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. , 1987, Journal of immunology.

[56]  M. Brunda,et al.  Differential antiproliferatve effects of combinations of recombinant interferons alpha and gamma on two murine tumor cell lines , 1986 .

[57]  R. Tubbs,et al.  Enzyme immunohistochemistry: technical aspects. , 1984, Seminars in diagnostic pathology.

[58]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[59]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[60]  M. Meltzer,et al.  Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice. , 1976, Cellular immunology.

[61]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.